Pharming Group N.V. (PHAR) Operating income 2019–2025
Pharming Group N.V. (PHAR) annual operating income history from SEC filings — each fiscal year as reported.
$25.8MFY2025 · since FY2019: $68.2M → $25.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.8M | +399.8% |
| FY2024 | -$8.6M | -60.0% |
| FY2023 | -$5.4M | -129.5% |
| FY2022 | $18.2M | +34.5% |
| FY2021 | $13.6M | -82.2% |
| FY2020 | $76.3M | +11.7% |
| FY2019 | $68.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice